Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, ...

Eli Lilly is exploring partnerships with Indian pharma firms to market its anti-diabetes and weight loss drug Mounjaro, ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Dr. Jitendra Singh, a renowned endocrinologist himself, emphasized the unique metabolic challenges faced by India due to its ...

President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...

Korean automaker Hyundai is the latest to announce plans to boost investment in the U.S. to ramp up domestic manufacturing.

China is making efforts to highlight the country’s business opportunities to major American corporations like Apple (AAPL), ...

Foreign CEOs, including Tim Cook of Apple, as well as Republican Sen. Steve Daines are in Beijing for the two-day China ...

China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, ...

U.S. Republican Senator Steve Daines, a staunch supporter of President Donald Trump, met Li on Sunday with seven senior ...

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years, including four new manufacturing plants. A number of companies have highlighted ...